BBH
BBH
About VanEck Biotech ETF
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
About VanEck Biotech ETF
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 AMGN | Amgen Inc. | 14.93% | 172.40K | $58.90M |
 GILD | Gilead Sciences, Inc. | 13.81% | 438.09K | $54.48M |
 VRTX | Vertex Pharmaceuticals Incorporated | 9.24% | 75.26K | $36.44M |
 REGN | Regeneron Pharmaceuticals, Inc. | 7.71% | 37.44K | $30.41M |
 IQV | IQVIA Holdings Inc. | 4.67% | 75.44K | $18.43M |
 NTRA | Natera, Inc. | 4.51% | 69.85K | $17.77M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 4.45% | 41.58K | $17.57M |
 ARGX | argenx SE | 4.38% | 20.99K | $17.28M |
 INSM | Insmed Incorporated | 3.95% | 88.59K | $15.59M |
 ONC | BeOne Medicines Ltd. | 3.30% | 39.01K | $13.02M |
 BIIB | Biogen Inc. | 3.18% | 67.10K | $12.54M |
 UTHR | United Therapeutics Corporation | 2.91% | 22.82K | $11.49M |
 ILMN | Illumina, Inc. | 2.83% | 74.32K | $11.16M |
 ICLR | ICON Public Limited Company | 2.60% | 50.45K | $10.24M |
 EXAS | Exact Sciences Corporation | 2.09% | 81.16K | $8.25M |
 INCY | Incyte Corporation | 2.08% | 74.11K | $8.19M |
 NBIX | Neurocrine Biosciences, Inc. | 1.83% | 51.39K | $7.23M |
 MRNA | Moderna, Inc. | 1.83% | 201.37K | $7.23M |
 BNTX | BioNTech SE | 1.82% | 71.57K | $7.16M |
 CRL | Charles River Laboratories International, Inc. | 1.43% | 26.08K | $5.65M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Switzerland
Ireland
GermanySECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Switzerland Ireland GermanyHoldings (Top 20)
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
IQV
IQVIA Holdings Inc.
NTRA
Natera, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
ARGX
argenx SE
INSM
Insmed Incorporated
ONC
BeOne Medicines Ltd.
BIIB
Biogen Inc.
UTHR
United Therapeutics Corporation
ILMN
Illumina, Inc.
ICLR
ICON Public Limited Company
EXAS
Exact Sciences Corporation
INCY
Incyte Corporation
NBIX
Neurocrine Biosciences, Inc.
MRNA
Moderna, Inc.
BNTX
BioNTech SE
CRL
Charles River Laboratories International, Inc.